bioRxiv Science⌕ Search

Biology subjects

Zamora, L.

Publications and source records attributed to Zamora, L..

2 recordsLinked to original sources

A novel crustavirus associated with tail fan necrosis in New Zealand red rock lobsters, Jasus edwardsii

Tail fan necrosis (TFN) is a shell disease affecting spiny lobsters outer integument, with significant implications for the health and commercial viability of red rock lobsters (Jasus edwardsii) in New Zealand. Despite its impact, the potential role of a microbial agent in TFN remains poorly understood. Here, we conducted metatranscriptomic analyses on matching uropod and haemolymph samples from 15 red rock lobsters exhibiting TFN symptoms to characterise the associated microbial communities and search for putative candidates for further investigation. We report the discovery of a novel crustavirus (family: Nyamiviridae), named Red rock lobster crustavirus (RRLCV), consistently present in the uropod tissues of all sampled lobsters with TFN. RRLCVs presence and high abundance in uropod tissues suggest a potential association with TFN, although we found no direct relationship between viral abundance and TFN severity metrics, such as tissue loss. We also identified 30 bacterial genera across uropod samples, including previously associated groups, however, these were detected inconsistently. Our findings raise new questions about the tissue tropism, transmission, and potential pathogenicity of RRLCV in red rock lobsters. While TFN appears to be a multifactorial condition, RRLCV represents a promising candidate for further research into its role in the development of this disease.

microbiology↗

Quantification of histone H1 subtypes using targeted proteomics.

Histone H1 is involved in the regulation of chromatin structure. Human somatic cells express up to seven subtypes. The variability in the proportions of somatic H1s (H1 complement) is one evidence supporting their functional specificity. Alterations in the protein levels of different H1 subtypes have been observed in cancer, suggesting their potential as biomarkers and that they might play a role in disease development. We have developed a mass spectrometry based (MS) parallel reaction monitoring (PRM) assay suitable for the quantification of H1 subtypes. Our PRM method is based on the quantification of unique peptides for each subtype, providing high specificity. Evaluation of the PRM performance on three human cell lines showed high reproducibility and sensitivity. Quantification values agreed with the electrophoretic and Western blot data, indicating the accuracy of the method. We used PRM to quantify the H1 complement in peripheral blood samples of healthy individuals and chronic myeloid leukemia (CML) patients. Our preliminary data revealed differences in the H1 complement between responders and non-responder CML patients and suggest that the H1 content could help predicting imatinib response.

biochemistry↗